Іздеу

Шығарылым
Атауы
Авторлар
Combination therapy for type 2 diabetes maintains its position. Clinical case
Podachina S., Biryukova E., Solovievа I.
Tactics of hypoglycemic treatment in patients with pancreatogenic diabetes: a prospective study
Nikulin I., Bagriy A., Mikhailichenko E., Kutya A., Sovpel Y.
The effectiveness of the use of natural mineral water “Donat” in the complex therapy of lipid and carbohydrate metabolism disorders
Mubarakshina O., Elizarova I., Cherenkova O.
Treatment options for different subtypes of gestational diabetes
Davidenko I., Volkova N., Degtyareva Y.
Glycemic variability diary as a tool for assessing the effectiveness of diabetes therapy. Clear and accessible. Case series
Smirnova E.
Theory and practice of use of dipeptidyl peptidase-4 inhibitors: focus on evogliptin
Biryukova E.
Microcirculation disorders in diabetic patients
Zelenina T., Zemlianoi A., Salukhov V., Ismailov D.
Metabolic comorbidity of endometritis after caesarean section
Korobkov N., Bakulina N., Borovik N.
Glucometer with a mobile application as a system for remote control of diabetes
Koteshkova O., Dukhareva O., Demidov N., Antsiferov M., Golubeva Y.
Features of compensation of carbohydrate metabolism in patients with type 2 diabetes mellitus hospitalized with coronavirus infection
Markova T., Anchutina A., Stas M., Medzhidova M.
Modern possibilities for correcting the uric acid level and eliminating skin manifestations of gout
Vereshchagin E., Svechnikova E., Arutyunyan G., Artemyeva N., Devyatova A., Sherf A.
Problems of pancreas transplantation and the role of bioengineered materials in long-term survival and functioning of islet cells
Bulgakova S., Sharonova L., Dolgikh Y., Kosareva O., Treneva E., Kurmaev D.
Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination
Biryukova E., Shinkin M., Morozova I.
Screening, diagnosis and treatment of early carbohydrate metabolism disorders
Demidova I., Boeva V.
Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection
Zhurtova I., Gubachikova A., Aramisova L., Anaeva L., Abdul Moati H.
Vildagliptin – 15 years in active service with diabetologists
Pavlova M.
Modern technologies in diabetes management
Koteshkova O., Antsiferov M., Antsiferova D., Demidov N.
The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus
Petrov V., Shatalova O., Klykova M., Stetsky N.
Clinical case of achieving compensation for type 2 diabetes mellitus in preparation for pregnancy in a woman of reproductive age
Markina J.
The use of dulaglutide in real clinical practice in patients with type 2 diabetes mellitus in Moscow
Antsiferov M., Antsiferova D., Koteshkova O., Demidov N.
Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes mellitus: how to choose the right solution
Antsiferov M., Koteshkova O., Antsiferova D., Demidov N.
How to improve the quality of type 2 diabetes mellitus management in routine clinical practice. experience of using a glycemic variability diary
Astamirova K., Gatina A., Gorbunova Y., Demidov N., Ivanenko T., Kolesnikova M., Lapteva O., Morozova I., Parshina V., Presnyakova O., Smirnova E., Smirnova N., Startseva M., Khamrazhanov Z., Kholmskaya N.
Intensification of diabetes therapy using insulin degludec. A series of atypical clinical cases
Smirnova E.
Dipeptyl peptidase type 4 inhibitors for modern therapy of type 2 diabetes mellitus
Demidov N.
Safety of continuous glycemic monitoring system in patients after total duodenopancreatectomy in the early postoperative period. Single-center retrospective cohort study
Farmanov A., Bublik E., Vinogradskaya O., Udovichenko O., Zilov A., Ryzhkova E., Egorov V., Fadeev V., Deunezheva S., Zhivov A., Tobianskaya I.
Comparative characteristics of the incidence of various endocrinopathies in cancer patients receiving treatment with immune checkpoint inhibitors
Zhurtova I., Aramisova L., Abdul Moati H., Arkhestova D., Khachmakhova E.
Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Ignatenko A., Bagriy A., Prikolota A., Prikolota O., Mikhailichenko E., Golodnikov I., Bagriy O.
Diabetes mellitus and new coronavirus infection: a look into the past; conclusions on prevention and treatment tactics for the future
Aramisova L., Zhurtova I., Gubachikova A.
Analysis of the quality of clinical follow-up care of patients with type 2 diabetes mellitus
Demicheva T.
Sulodexide: meta-analysis of the treatment of diabetic nephropathy and literature review
Novikova M., Koteshkova O., Antsiferov M.
Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice
Elsukova O., Nikitina E., Chuprova A., Kaysina O.
Modern and safe treatment of type 2 diabetes mellitus. Clinical case of the use of gozogliptin in the treatment of a patient with decompensated diabetes mellitus
Smirnova E.
Cohort study of clinical and anamnestic characteristics of patients with a combination of type 2 diabetes mellitus and irritable bowel syndrome
Suprun O., Bagriy A., Mikhailichenko E., Andreeva E., Evtushenko A., Suprun E.
Intensification of glucose-lowering therapy for type 2 diabetes mellitus using insulin degludec: clinical case analysis
Elsukova O.
Modern possibilities for assessing glycemia in diabetic patients
Chernikova N., Degtyareva E.
Pharmacotherapeutic aspects of gestational diabetes mellitus against the background of impaired maternal immunity
Kazimova A., Polukhova S.
Monogennye formy sakharnogo diabeta
Zubkova N., Tikhonovich Y., Tyul'pakov A.
Optimization of the diabetes screening questionnaire for patients with psoriasis
Morzhanaeva M., Svechnikova E.
Application of the diabetes screening questionnaire in patients with psoriasis
Morzhanaeva M., Svechnikova E., Shchepkina E., Kuznetsov A.
Obespechennost' vitaminom D i metabolicheskie narusheniya: sistematicheskiy analiz fundamental'nykh i dokazatel'nykh issledovaniy po problemam izbytochnoy massy tela i sakharnogo diabeta
Gromova O., Torshin I., Limanova O., Grishina T., Gromov A.
Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus
Bagriy A., Shchukina E., Efremenko V., Mikhailichenko E., Suprun E.
Rol' terapevticheskogo obucheniya patsientov na pompovoy insulinoterapii
Ametov A., Valitov B., Chernikova N., Antsiferov M.
News of medicine
Kudinova S.
Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice
Antsiferov M., Zilov A., Koteshkova O., Demidov N.
PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS
Ametov A.
Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakharnym diabetom 2011 g.: osnovnye izmeneniya
Mayorov A.
GLYCEMIC VARIABILITY AS A THERAPEUTIC TARGET IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
Ametov A., Chernikova N., Demidova T., Nazhmutdinova P.
DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE
Peterkova V., Peterkova V.
SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS
Druk I., Nechaeva G., Korennova O., Druk I., Nechayeva G., Korennova O.
Experience in the integrated use of organizational approaches and clinical tools to achieve glycemic control goals
Antsiferov M., Demidov N.
Type 3 diabetes mellitus: is there a chance to become famous?
Morgunov L.
Diabetic neuropathy: pathophysiological mechanisms and metabolic therapy
Kurnikova I.
Possibilities of using trimetazidine in comorbid cardiovascular pathology and metabolic disorders
Nikiforov V.
Features of the pathogenesis and treatment of diabetes mellitus during the COVID-19 pandemic
Bagriy A., Mikhailichenko E., Prikolota A., Mogilevskaya K.
Problem of treatment adherence in patients with type 2 diabetes mellitus
Akulova A., Zhulina Y., Rozhkova V., Martynova E., Poteshkin Y.
Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus
Antsiferov M., Koteshkova O., Novikova M., Demidov N.
What should the practitioner remember when managing patients with diabetic neuropathy
Isakova E., Kotov S.
Combination of two hypoglycemic drugs for type 2 diabetes mellitus
Morgunova T., Fadeyev V.
Does autoimmune thyroiditis affect the clinical course of type 1 diabetes mellitus in children, regardless of the functional state of the thyroid gland?
Abdullaev A., Litvinova D., Rozhkov N., Kiyaev A.
Hypoglycemic drugs and drug-induced heart failure
Ostroumova O., Goloborodova I.
Prevention of blindness in diabetes mellitus. From retinal laser coagulation to pharmacology
Shadrichev F., Demidova T., Grigorieva N., Kozhevnikov A.
Poststroke recovery in patients with type 2 diabetes mellitus
Tanashyan M., Maksimova M., Antonova K., Raskurazhev A., Shakhparonova N., Romantsova T.
ASSESSMENT OF THE EFFICACY AND SAFETY OF INSULIN DEGLUDEC IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS IN REAL-LIFE CLINICAL PRACTICE
Kiyaev A., Kondrashova O., Chernykh L., Pollyak O., Yusupova A., Slovak M., Zaykova I.
Effect of SGLT-2 inhibitors on cardiovascular outcomes: review of results of CVD-REAL trial
Antsiferov M.
THE USE OF ANTIBACTERIAL DRUGS DURING ORTHOPAEDIC ALIGNMENT WITH REMOVABLE LAMINAR DENTURES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TAKING INTO ACCOUNT THE RESULTS OF PCR-BASED DIAGNOSTICS
Shevkunova N.
SAFE AND EFFECTIVE COMBINATION OF ULTRALONG-ACTING BASAL INSULIN DEGLUDEC AND ULTRA-SHORT ACTING INSULINE ASPART IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
Girsh Y., Veliyeva O.
Current approaches to therapy of type 2 diabetes mellitus in the era of new data on cardiovascular safety
Antsiferov M., Schernthaner G.
DIABETIC ANGIOPATHY «PAINFUL» POINTS: FOCUS ON HYPERTRIGLYCERIDEMIA AND FENOFIBRATE POTENTIAL
Rujatkina L., Rujatkin D., Zemljanuhina S.
10 let ispol'zovaniya pompovoy insulinoterapii v moskovskoy pediatricheskoy praktike -
Rybkina I., Petryaykina E., Koltunov I.
Preimushchestva fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysvobozhdeniya (Kombogliz Prolong) v terapii SD 2 tipa
Ametov A.
Statiny i risk vozniknoveniya novykh sluchaev sakharnogo diabeta: sootnoshenie riska i pol'zy. Sovremennye predstavleniya o tselevykh urovnyakh lipidov u patsientov s sakharnym diabetom
Shalaev S., Safiullina Z., Mikhal'chuk N.
PATOGENETIChESKIE PODKhODY K TERAPII DIABETIChESKOY POLINEVROPATII
Badalyan O., Savenkov A.
Osobennosti terapii perenesennogo insul'ta u bol'nykh sakharnym diabetom
Shavlovskaya O.
Rol' i mesto gipoglikemii v upravlenii sakharnym diabetom 2 tipa
Chernikova N., Antsiferov M.
SAKhARNYY DIABET 2 TIPA I NEALKOGOL'NAYa ZhIROVAYa BOLEZN' PEChENI: PRAKTIChESKIE REKOMENDATsII DLYa ENDOKRINOLOGOV
Ametov A.
Vybor gliptinov v raznykh klinicheskikh situatsiyakh - kommentarii k portretam patsientov
Ruyatkina L., Sorokin M.
TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®)
Antsiferov M., Petunina N., Antsiferov M., Petunina N.
Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu
Antsiferov M., Antciferov M.
DIABETIC AUTONOMIC NEUROPATHY AND DIGESTIVE ORGANS
Pogromov A., Baturova V., Pogromov A., Yu Baturova V.
INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES
Antsiferov M., Koteshkova O., Kleymenova S., Antsiferov M., Koteshkova O., Kleimenko S.
WHEN TO BEGIN COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N., Petunina N.
ANTIOXIDANT THERAPY OF DIABETIC POLYNEUROPATHY
Tabeeva G., Azimova Y., Tabeeva G., Azimova Y.
Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?
Nedosugova L., Nedosugova L.
The effectiveness of the drug Vessel Due F in patients with diabetes with nonproliferative and preproliferative diabetic retinopathy
Ishchenko I., Milen'kaya T., Ischenko I., Milenkaya T.
Modern possibilities for correcting the uric acid level and eliminating skin manifestations of gout
Vereshchagin E., Svechnikova E., Artemyeva N.
Multiple thyroid carcinoma and other long-term endocrine consequences of chemoradiotherapy for medulloblastoma: a clinical case
Khruleva Y., Amergulov I., Likhodey N., Dzyuba A., Sych Y., Pavlova M.
Dermatoses in elderly diabetic patients
Ladygina D., Zheleznyakova A.
Is non-alcoholic fatty liver disease a consequence of obesity and a predictor of diabetes?
Volkova N., Panenko S., Golubeva A.
Testosterone replacement therapy in men with type 2 diabetes mellitus and neuropathy
Zelenina T., Salukhov V., Zemlyanoy A., Chebykina O.
The use of fixed ratio combination of insulin glargine and lixisenatide in patients with type 2 diabetes mellitus in real clinical practice. Own clinical experience
Khamnueva L., Andreeva L., Davydova A., Chugunova E., Tokareva N., Molodtsova N.
Modern approaches to using the FreeStyle Libre Flash glucose monitoring system
Demidov N., Koteshkova O., Antsiferov M.
Modern approaches to the choice of hypoglycemic therapy in patients with type 2 diabetes mellitus: a niche of DPP-4 inhibitors
Chernikova N., Knyshenko O.
The state of carbohydrate metabolism and the development of cerebrovascular diseases in patients with type 2 diabetes mellitus
Antonova K., Tanashyan M., Maksimova M., Shakhparonova N., Romantsova T.
Application of Cocarnit in complex treatment of patients with diabetic polyneuropathy in outpatient practice
Novikova L., Tarkhanova I., Dmitrieva O., Fomichev A., Kakaulina L.
NEW POSSIBILITIES OF CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Verbovoy A., Pashentseva A., Verbovaya N., Kosareva O.
The use of insulin glargine 300 lU/ml (Toujeo SoloStar®) in real clinical practice
Antsiferov M.
CURRENT POSSIBILITIES OF COMBINED THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Chemikova N.
Features of use of dapagliflozin in thetreatment of patients with type 2 diabetes mellitus
Antsiferov M.
OVERVIEW OF PHARMACOECONOMIC STUDIES OF INSULIN PUMP THERAPY IN DIABETES MELLITUS
Tolkushin A.
Sakharosnizhayushchiy effekt flozinov po sravneniyu s preparatami sul'fonilmocheviny u patsientov s sakharnym diabetom 2 tipa
Galstyan G.
Нәтижелер 305 - 1/100 1 2 3 4 > >> 
Сыбырсөздер:
  • Негізгі сөздер тіркелімге сезімтал< / li>
  • Ағылшын предлогтары мен одақтары еленбейді
  • Әдепкі бойынша іздеу барлық негізгі сөздер үшін жасалады (агенс AND экспериенцер)
  • Белгілі бір терминді табу үшін OR қолданыңыз. білім беру OR оқыту
  • мысалы, күрделі сөз тіркестерін жасау үшін жақшаларды қолданыңыз. мұрағат ((журналдар OR конференциялар) NOT диссертациялар)
  • Нақты фразаны табу үшін, мысалы, тырнақшаларды қолданыңыз. "ғылыми зерттеулер"
  • сөзді - (сызықша) немесе not операторының көмегімен алып тастаңыз; мысалы. сұлулық байқауы< / em > немесе сұлулық байқауы< / em > < / li>
  • мысалы, нұсқа ретінде * қолданыңыз. ғылым* "ғылыми","ғылыми"және т. б. сөздерді қамтиды< / li> < / < / к-сі>

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>